MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Intrinsic Auricular Muscle Zone Stimulation for Moderate-to-Severe Parkinson’s Disease

    S. Brillman, A. Samiian, V. Sharma, S. Ertan, . öztop çakmak (Palo Alto, USA)

    Objective: To assess the effects of electrical stimulation of the Intrinsic Auricular Muscle Zone (IAMZ) on motor symptoms in patients with moderate-to-severe Parkinson’s disease (PD).…
  • 2024 International Congress

    GRoningen Early-PD Ambroxol Treatment (GREAT) Trial: A randomized, double-blind, placebo-controlled, single center trial with ambroxol in Parkinson patients with a GBA-mutation

    O. Siemeling, S. Slingerland, S. V/d Zee, T. van Laar (Groningen, Netherlands)

    Objective: To study the potential disease-modifying properties of ambroxol in PD patients with a GBA1 mutation Background: The most common genetic risk factor for Parkinson’s…
  • 2024 International Congress

    A Pilot Study of Intrajejunal Faecal Microbiota Transplant to Improve Motor Function in Patients with Parkinson’s Disease Treated with Levodopa-carbidopa Intestinal Gel: Preliminary Findings.

    D. Wilson, L. Williams, S. Waller, S. Dal, J. Qiu, D. Tsui, S. Bray, J. Griffith, D. Galea, X. Chen, F. Tudehope, L. Bracken, H. Morales-Briceno, N. Mahant, F. Chang, S. Bandodkar, D. Van-Der-Poorten, V. Fung (Sydney, Australia)

    Objective: To determine whether faecal microbiota transplant (FMT) improves motor function in patients with Parkinson Disease (PD) treated with levodopa/carbidopa intestinal gel (LCIG). Background: Preliminary…
  • 2024 International Congress

    Long-Term Evolution of Advanced Parkinson’s Disease Burden: Subgroup Analysis from the 24 Month International PROSPECT Observational Study

    O. de Fabregues, D. Falconer, S. Heshmat, D. Houghton, D. Maltete, Y. Mukai, M. Rollins, L. Bergmann, P. Kukreja, K. Onuk, J. Sarna (Barcelona, Spain)

    Objective: To evaluate the long-term evolution of clinical outcomes and treatment patterns in people with advanced Parkinson’s disease (PwaPD) whose symptoms are inadequately controlled by…
  • 2024 International Congress

    Meta-Analysis of Two Randomized Controlled Trials Assessing the Efficacy of Mesdopetam (IRL790) in Levodopa-Induced Dyskinesia in Parkinson’s Disease

    F. Hansson, S. Waters, N. Waters, J. Tedroff (Gothenburg, Sweden)

    Objective: To evaluate the efficacy of mesdopetam for the treatment of levodopa-induced dyskinesia in Parkinson’s disease (PD-LID), based on two Phase 2 trials. Background: Mesdopetam…
  • 2024 International Congress

    Mortality Rate, Cause of Death and Factors Associated with Mortality in Late Stage Parkinson’s Disease

    K. Rosqvist, P. Odin (Lund, Sweden)

    Objective: The aim was to carry out a long-term follow-up of a cohort of patients in late stage Parkinson’s disease (PD) with focus on mortality…
  • 2024 International Congress

    Effects of ectopic dopamine D2 autoregulation of raphe-striatal projecting neurons on established L-DOPA-mediated behaviors in a hemiparkinsonian rat model

    A. Centner, N. Lipari, C. Budrow, G. Mcmanus, I. Sandoval, K. Tseng, F. Manfredsson, C. Bishop (Binghamton, USA)

    Objective: Levodopa (LD) is the standard treatment for Parkinson’s Disease (PD) despite risk of LD-induced dyskinesia (LID) development within a decade of treatment. Serotonergic (5-HT)…
  • 2024 International Congress

    Trends in Physiotherapy Interventions and Medical Costs for Parkinson’s Disease in South Korea, 2011–2020

    DW. Ryu, MJ. Lee, JS. Park, DL. Yoo, SM. Cheon ()

    Objective: We analyzed trends in PT interventions and associated medical costs among South Korean patients with PD between 2011 and 2020. Background: Physiotherapy (PT), an…
  • 2024 International Congress

    Oropharyngeal Adverse Events in Parkinson’s Patients with Motor Fluctuations Treated with Apomorphine Sublingual Film

    L. Wojtecki, F. Moreira, E. Cubo, M. Fonseca, G. Harrison-Jones, C. Denecke Muhr (Düsseldorf, Germany)

    Objective: This post-hoc analysis of Study CTH-301 assessed the occurrence of oropharyngeal treatment-emergent adverse events (TEAEs) in patients with Parkinson’s disease included in this study.…
  • 2024 International Congress

    Moderators of aerobic exercise effects on motor symptoms in patients with Parkinson’s disease: a systematic review and meta-analysis

    R. Kim, N. Kang (Seoul, Republic of Korea)

    Objective: To investigate the difference in the effects of aerobic exercise on motor function in patients with Parkinson's disease (PD) according to exercise intervention protocols.…
  • « Previous Page
  • 1
  • …
  • 107
  • 108
  • 109
  • 110
  • 111
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley